Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 1
Submit an article Journal homepage
4,275
Views
23
CrossRef citations to date
0
Altmetric
Review

The importance of correctly timing cancer immunotherapy

Elham Beyranvand NejadDepartment of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands;Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The NetherlandsView further author information
,
Marij J.P. WeltersDepartment of Medical Oncology, Leiden University Medical Center, Leiden, The NetherlandsView further author information
,
Ramon ArensDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The NetherlandsView further author information
&
Sjoerd H. van der BurgDepartment of Medical Oncology, Leiden University Medical Center, Leiden, The NetherlandsCorrespondence[email protected]
View further author information
Pages 87-103 | Received 23 May 2016, Accepted 31 Oct 2016, Published online: 16 Nov 2016

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Reza Alimohammadi, Razieh Alibeigi, Amin Reza Nikpoor, Ghanbar Mahmoodi Chalbatani, Thomas J Webster, Mahmoud Reza Jaafari & Seyed Amir Jalali. (2020) Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy. International Journal of Nanomedicine 15, pages 5279-5288.
Read now

Articles from other publishers (22)

Nirjari Kothari, Humzah Postwala, Aanshi Pandya, Aayushi Shah, Yesha Shah & Mehul R. Chorawala. (2023) Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects. Medical Oncology 40:5.
Crossref
Cherine A. Ismail, Maha M. Eissa, Maha R. Gaafar, Layla K. Younis & Nahla El Skhawy. (2023) Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide. Medical Oncology 40:5.
Crossref
Lien Lybaert, Steve Lefever, Bruno Fant, Evelien Smits, Bruno De Geest, Karine Breckpot, Luc Dirix, Steven A. Feldman, Wim van Criekinge, Kris Thielemans, Sjoerd H. van der Burg, Patrick A. Ott & Cedric Bogaert. (2023) Challenges in neoantigen-directed therapeutics. Cancer Cell 41:1, pages 15-40.
Crossref
Carlos J. Ortiz-Bonilla, Taylor P. Uccello, Scott A. Gerber, Edith M. Lord, Edward M. Messing & Yi-Fen Lee. (2022) Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity. International Journal of Molecular Sciences 23:6, pages 2904.
Crossref
Abazar Arabameri & Arash Pourgholaminejad. (2021) Modeling codelivery of CD73 inhibitor and dendritic cell-based vaccines in cancer immunotherapy. Computational Biology and Chemistry 95, pages 107585.
Crossref
Guofeng Ji, Yu Zhang, Xinghui Si, Haochen Yao, Sheng Ma, Yudi Xu, Jiayu Zhao, Chong Ma, Chaoliang He, Zhaohui Tang, Xuedong Fang, Wantong Song & Xuesi Chen. (2020) Biopolymer Immune Implants’ Sequential Activation of Innate and Adaptive Immunity for Colorectal Cancer Postoperative Immunotherapy. Advanced Materials 33:3, pages 2004559.
Crossref
Elisabete Ribeiro, Fernanda Marques, Lurdes Gano, João D.G. Correia, Isabel Santos & Célia Fernandes. (2020) Docetaxel-loaded block copolymer micelles labeled with 188Re for combined radiochemotherapy. Journal of Drug Delivery Science and Technology 60, pages 101898.
Crossref
Slavisa Tubin, Weisi Yan, Waleed F Mourad, Piero Fossati & Mohammad K Khan. (2020) The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches. Future Oncology 16:16, pages 1137-1151.
Crossref
Slavisa Tubin, Martin Ashdown & Branislav Jeremic. (2019) Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment. Radiation Oncology 14:1.
Crossref
Tom J. Harryvan, Els M. E. Verdegaal, James C. H. Hardwick, Lukas J. A. C. Hawinkels & Sjoerd H. van der Burg. (2019) Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies. Journal of Clinical Medicine 8:11, pages 1989.
Crossref
Kyle M. Garland, Sema Sevimli, Kameron V. Kilchrist, Craig L. Duvall, Rebecca S. Cook & John T. Wilson. (2019) Microparticle Depots for Controlled and Sustained Release of Endosomolytic Nanoparticles. Cellular and Molecular Bioengineering 12:5, pages 429-442.
Crossref
Magdalena Jarosz-Biej, Ryszard Smolarczyk, Tomasz Cichoń & Natalia Kułach. (2019) Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy. International Journal of Molecular Sciences 20:13, pages 3212.
Crossref
Fuat Karakuş, Kadir Yılmaz, Ergül Eyol & Songül Ünüvar. (2019) Combination of 2 Bioactive Compounds for Treatment of Breast Cancer: Triterpenoid Cucurbitacin I and Phenolic CAPE. Natural Product Communications 14:6, pages 1934578X1985749.
Crossref
Robert A. Belderbos, Joachim G.J.V. Aerts & Heleen Vroman. (2019) Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment. Molecular Therapy - Oncolytics 13, pages 67-81.
Crossref
Alice Mougel, Magali Terme & Corinne Tanchot. (2019) Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade. Frontiers in Immunology 10.
Crossref
Mandy van Gulijk, Floris Dammeijer, Joachim G. J. V. Aerts & Heleen Vroman. (2018) Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy. Frontiers in Immunology 9.
Crossref
Adrianna Grzelak, Ingrid Polakova, Jana Smahelova, Julie Vackova, Lucie Pekarcikova, Ruth Tachezy & Michal Smahel. (2018) Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation. International Journal of Molecular Sciences 19:11, pages 3693.
Crossref
David Paßlick, Keti Piradashvili, Denise Bamberger, Mengyi Li, Shuai Jiang, Dennis Strand, Peter R. Wich, Katharina Landfester, Matthias Bros, Stephan Grabbe & Volker Mailänder. (2018) Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation. Journal of Controlled Release 289, pages 23-34.
Crossref
Hathaichanok Phuengkham, Chanyoung Song, Soong Ho Um & Yong Taik Lim. (2018) Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy. Advanced Materials 30:18, pages 1706719.
Crossref
Liam F. Tremble, Morgan A. O'Brien, Patrick F. Forde & Declan M. Soden. (2018) ICOS activation in combination with electrochemotherapy generates effective anti-cancer immunological responses in murine models of primary, secondary and metastatic disease. Cancer Letters 420, pages 109-115.
Crossref
Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, Clark C Anderson, Hampartsoum B Barsoumian, Ahmed I Younes, Lakshmi S K Mahadevan, Melinda Soeung, Kathryn E Aziz, James W Welsh & Sunil Krishnan. (2018) Radiation therapy and immunotherapy: what is the optimal timing or sequencing?. Immunotherapy 10:4, pages 299-316.
Crossref
Maëlle Anciaux, Caroline Vandeputte & Alain Hendlisz. (2017) Tackling immunomonitoring in gastrointestinal cancer. Current Opinion in Oncology 29:4, pages 296-305.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.